Work on the structure of the market driven development process is
under way. This includes specification of new products in accordance
with the internationally accepted RUP (Rational Unified Process)
right through from the market analysis phase. Moreover the installation,
support and testing functions have been brought together
in order to increase client focus and product knowledge within the
installation and support functions.
Open interfaces with regulatory quality assurance
There is still a strong focus on improving the integration capabilities of our products as this is one of the main factors in our success. This applies to our products, regulatory considerations and of course the way in which we sell and install our products. We can now offer our customers integration without having to change our basic software. Our products are always developed in such a way as to conform to medical technology regulations. This is achieved using a risk-based approach, and clear system architecture with standardised interfaces.
Strategies for platforms and modularisation
The platform initiative is going as planned, bringing more internal efficiency throughout the company and providing customers with a modular product with a secure future. Platforms mean that synergies in product development and resources can now be exploited between the different Ortivus companies. An example took place in 2008 when staff from Sweden was loaned out to the development centre in Canada, achieving optimum lateral benefit.
Project management and continuity
Previously initiated improvement work on projects and processes is on-going and will continue to be developed for many years. Further areas of work to give Ortivus the conditions for growth have been identified.
Corner stones in our development strategy:
• Clear, market driven development
• Solutions that provide IT interfaces for customers’ existing applications
• Strategy for platforms and modularisation
• Clear project management and continuity